tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Castle Biosciences Inc

CSTL
Add to Watchlist
28.090USD
+1.300+4.85%
Close 07-31 16:00（ET）Quotes delayed by 15 min
856.98MMarket Cap
LossP/E TTM

Castle Biosciences Inc

28.090
+1.300+4.85%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

CSTL Financials

See Castle Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Castle Biosciences Inc Earnings Date

Latest Release
Jul 30, 2026
EPS / Forecast
-0.06/-0.41
Revenue / Forecast
103.55M/86.24M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
344.23M
3.66%
EPS(YoY)
-0.83
-226.88%
Analyst Rating
STRONG BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-135.54%-0.06
46.22%-0.49
-123.31%-0.08
-121.14%-0.02
-51.52%0.16
-879.92%-0.90
457.24%0.34
131.67%0.08
145.94%0.32
91.60%-0.09
87.78%-0.10
---0.26
---0.70
---1.10
---0.78
---1.79
----
----
----
----
Revenue
20.14%103.55M
-4.90%83.68M
0.81%87.01M
-3.19%83.04M
-0.94%86.19M
20.57%87.99M
30.54%86.31M
39.50%85.78M
73.53%87.00M
73.59%72.97M
72.47%66.12M
66.15%61.49M
43.92%50.14M
56.55%42.04M
53.11%38.34M
57.66%37.01M
53.08%34.84M
17.70%26.85M
44.74%25.04M
54.27%23.48M
Net Profit
-137.36%-1.69M
43.82%-14.52M
-124.32%-2.33M
-122.08%-501.00K
-49.29%4.52M
-920.05%-25.85M
471.71%9.59M
132.86%2.27M
147.50%8.92M
91.32%-2.53M
87.49%-2.58M
65.90%-6.91M
-1039.38%-18.78M
-18.60%-29.20M
-220.65%-20.62M
-71.73%-20.25M
81.25%-1.65M
-475.30%-24.62M
-31.52%-6.43M
-156.94%-11.79M
Net Margin
-131.10%-1.63%
40.92%-17.35%
-124.12%-2.68%
-122.81%-0.60%
-48.81%5.25%
-745.99%-29.38%
384.75%11.11%
123.56%2.65%
127.38%10.25%
95.00%-3.47%
92.74%-3.90%
---11.23%
---37.45%
---69.47%
---53.78%
---47.13%
----
----
----
----
Gross Margin
-3.02%74.94%
48.01%72.80%
0.15%76.33%
-5.58%74.74%
-4.28%77.27%
-36.84%49.19%
-2.00%76.22%
1.61%79.16%
9.89%80.73%
10.48%77.88%
12.09%77.78%
--77.90%
--73.46%
--70.49%
--69.39%
--71.08%
----
----
----
----
Debt to assets ratio
-3.54%1.84%
3.35%2.13%
-7.84%1.81%
-7.82%1.85%
-9.81%1.91%
-5.47%2.06%
9174.27%1.96%
24142.98%2.00%
19065.07%2.12%
16860.25%2.18%
-60.19%0.02%
--0.01%
--0.01%
--0.01%
--0.05%
--0.03%
----
----
----
----
Income Statement
Revenue
20.14%103.55M
-4.90%83.68M
0.81%87.01M
-3.19%83.04M
-0.94%86.19M
20.57%87.99M
30.54%86.31M
39.50%85.78M
73.53%87.00M
73.59%72.97M
72.47%66.12M
66.15%61.49M
43.92%50.14M
56.55%42.04M
53.11%38.34M
57.66%37.01M
53.08%34.84M
17.70%26.85M
44.74%25.04M
54.27%23.48M
Operating profit
27.78%-3.07M
34.09%-18.41M
-194.49%-3.83M
-233.96%-6.80M
-184.82%-4.25M
-410.47%-27.93M
171.58%4.05M
152.69%5.08M
123.69%5.01M
82.64%-5.47M
75.54%-5.66M
55.55%-9.64M
13.18%-21.16M
-43.58%-31.52M
-52.48%-23.13M
-83.57%-21.69M
-176.61%-24.37M
-412.46%-21.95M
-400.36%-15.17M
-202.85%-11.81M
Net Profit
-137.36%-1.69M
43.82%-14.52M
-124.32%-2.33M
-122.08%-501.00K
-49.29%4.52M
-920.05%-25.85M
471.71%9.59M
132.86%2.27M
147.50%8.92M
91.32%-2.53M
87.49%-2.58M
65.90%-6.91M
-1039.38%-18.78M
-18.60%-29.20M
-220.65%-20.62M
-71.73%-20.25M
81.25%-1.65M
-475.30%-24.62M
-31.52%-6.43M
-156.94%-11.79M
Balance Sheet
Current assets
-2.17%341.10M
-5.86%328.90M
0.26%361.10M
3.71%357.57M
8.82%348.67M
18.13%349.39M
21.82%360.15M
23.30%344.77M
19.09%320.40M
9.10%295.78M
1.15%295.63M
-6.61%279.62M
-11.76%269.05M
-19.42%271.10M
-17.37%292.29M
-23.15%299.41M
-22.16%304.91M
-21.15%336.44M
-17.66%353.74M
93.76%389.58M
Total current liabilities
11.04%56.51M
30.82%48.76M
39.04%68.68M
24.86%55.31M
28.99%50.89M
16.63%37.27M
3.62%49.39M
21.94%44.30M
17.02%39.45M
6.02%31.96M
31.94%47.67M
13.72%36.32M
22.52%33.72M
-23.73%30.14M
45.17%36.13M
52.16%31.94M
47.52%27.52M
124.83%39.52M
19.21%24.89M
-30.58%20.99M
Total assets
3.02%561.18M
9.19%547.80M
8.91%578.56M
9.37%562.79M
11.78%544.73M
9.42%501.71M
17.18%531.24M
18.01%514.57M
14.55%487.31M
7.41%458.51M
1.34%453.34M
-4.76%436.02M
-7.19%425.40M
-3.95%426.89M
-3.30%447.33M
5.56%457.81M
5.25%458.38M
1.62%444.43M
5.29%462.57M
106.13%433.69M
Total liabilities
2.01%91.15M
40.68%86.39M
42.82%107.68M
30.24%95.74M
40.89%89.35M
9.57%61.41M
21.47%75.40M
46.33%73.51M
36.00%63.42M
34.27%56.05M
28.83%62.07M
8.32%50.24M
26.99%46.63M
-11.36%41.74M
-5.22%48.18M
111.01%46.38M
87.18%36.72M
151.21%47.09M
115.05%50.83M
-49.86%21.98M
Total equity
3.22%470.03M
4.79%461.42M
3.30%470.87M
5.89%467.05M
7.43%455.38M
9.40%440.31M
16.50%455.83M
14.33%441.06M
11.91%423.89M
4.50%402.46M
-1.97%391.27M
-6.23%385.78M
-10.17%378.77M
-3.07%385.15M
-3.06%399.15M
-0.07%411.43M
1.38%421.66M
-5.08%397.34M
-0.95%411.74M
147.19%411.71M
Cash Flow Statement
Net operating income
-26.99%15.20M
-266.62%-22.13M
10.53%26.93M
-3.03%22.63M
-13.24%20.82M
11.69%-6.04M
31.09%24.36M
365.64%23.34M
733.86%24.00M
73.13%-6.83M
409.78%18.59M
195.94%5.01M
57.94%-3.79M
-18.71%-25.44M
-115.75%-6.00M
14.82%-5.22M
-39.81%-9.00M
-490.20%-21.43M
-546.74%-2.78M
-107.55%-6.13M
Net investment
43.75%-15.96M
-15.03%-25.80M
53.05%8.83M
-24.34%-18.39M
-32.50%-28.38M
-13.86%-22.43M
175.21%5.77M
-52.34%-14.79M
-39.19%-21.42M
-218.80%-19.70M
-71.17%-7.67M
92.76%-9.71M
44.07%-15.39M
4225.37%16.58M
85.49%-4.48M
-14434.13%-134.15M
19.31%-27.51M
46.40%-402.00K
-5153.23%-30.89M
51.52%-923.00K
Net financing
-977.23%-886.00K
-224.08%-5.03M
14.78%-4.59M
-209.67%-919.00K
140.48%101.00K
-114.59%-1.55M
-63.33%-5.38M
1762.22%838.00K
-81.42%42.00K
1362.09%10.64M
-339.60%-3.30M
-88.40%45.00K
-65.81%226.00K
-40.13%728.00K
-695.24%-750.00K
-79.51%388.00K
-65.04%661.00K
-19.47%1.22M
-99.94%126.00K
-76.76%1.89M

FAQs

What is the total revenue of Castle Biosciences Inc?

According to Castle Biosciences Inc's FY2025 earnings report, its total revenue reached 344.23M, with a year-on-year change of 332.07M.

What are the current assets of Castle Biosciences Inc?

According to Castle Biosciences Inc's FY2025 earnings report, its current assets were 361.10M, with a year-on-year change of 0.26.

What are the total assets of Castle Biosciences Inc?

According to Castle Biosciences Inc's FY2025 earnings report, its total assets of Castle Biosciences Inc were 578.56M, with a year-on-year change of 8.91.

What are the total liabilities of Castle Biosciences Inc?

According to Castle Biosciences Inc's FY2025 earnings report, its total liabilities of Castle Biosciences Inc were 107.68M, with a year-on-year change of 42.82.

What is the total equity of Castle Biosciences Inc?

According to Castle Biosciences Inc's FY2025 earnings report, its total equity of Castle Biosciences Inc was 470.87M, with a year-on-year change of 3.30.

What is the net operating income of Castle Biosciences Inc?

According to Castle Biosciences Inc's FY2025 earnings report, its net operating income of Castle Biosciences Inc was -42.81M, with a year-on-year change of -593.77.

What is the net investment of Castle Biosciences Inc?

According to Castle Biosciences Inc's FY2025 earnings report, its net investment of Castle Biosciences Inc was -60.37M, with a year-on-year change of -20.40.

What is the net financing of Castle Biosciences Inc?

According to Castle Biosciences Inc's FY2025 earnings report, its net financing of Castle Biosciences Inc was -6.96M, with a year-on-year change of -213.37.

What is the Earnings Per Share (EPS) of Castle Biosciences Inc?

According to Castle Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.83, with a year-on-year change of -226.88.

What is the net income of Castle Biosciences Inc?

According to Castle Biosciences Inc's FY2025 earnings report, its net income was -24.16M, with a year-on-year change of -232.41.

What is the net margin of Castle Biosciences Inc?

According to Castle Biosciences Inc's FY2025 earnings report, its net profit margin was -7.02, with a year-on-year change of -227.73.

What is the gross margin of Castle Biosciences Inc?

According to Castle Biosciences Inc's FY2025 earnings report, its gross margin was 69.25, with a year-on-year change of -11.82.

What is the debt-to-asset ratio of Castle Biosciences Inc?

According to Castle Biosciences Inc's FY2025 earnings report, its debt-to-asset ratio was 1.81, with a year-on-year change of -7.84.

What is the Return on Equity (ROE) of Castle Biosciences Inc?

According to Castle Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -5.21, with a year-on-year change of -221.03.

What is the Return on Assets (ROA) of Castle Biosciences Inc?

According to Castle Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -4.35, with a year-on-year change of -217.47.

What is the operating profit of Castle Biosciences Inc?

According to Castle Biosciences Inc's FY2025 earnings report, its operating profit was -42.81M, with a year-on-year change of -593.77.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy